Get in Touch

Contact us for more information about Grifols

Call us

Grifols Customer Service
1-800-243-4153

Write to us

Grifols
79 TW Alexander Drive
4101 Research Commons
Research Triangle Park,
NC 27709

Fill out the form below and get in contact with us

All fields are required unless otherwise stated

First Name

Last Name

Email Address

Phone Number (Optional)

Comments

0 characters left

Data Protection Information
The Grifols' group company to which you submit the request, as data controller, will process your personal data to manage your requests of information, suggestions and/or queries. The legal basis is Grifols' legitimate interest. Your data may be shared with Grifols' group companies and other third parties. You have the right to access, rectify and erase, as well as any other rights detailed in the additional information. For additional information on personal data protection check here.

recaptcha-check Required

By clicking the button below, I declare being informed that my data is being used as described in the data protection information.

Important Safety Information for HyperTET^® (tetanus immune globulin [human])

HyperTET^® (tetanus immune globulin [human]) is indicated for prophylaxis against tetanus following injury in patients whose immunization is incomplete or uncertain.

HyperTET should be given with caution to patients with a history of prior systemic allergic reactions following the administration of human immunoglobulin preparations.

In patients who have severe thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injections, HyperTET should be given only if the expected benefits outweigh the risks.

Slight soreness at the site of injection and slight temperature elevation may be noted at times. Sensitization to repeated injections of human immunoglobulin is extremely rare. In the course of routine injections of large numbers of persons with immunoglobulin, there have been a few isolated occurrences of angioneurotic edema, nephrotic syndrome, and anaphylactic shock after injection. Administration of live virus vaccines (eg, MMR) should be deferred for approximately 3 months after tetanus immune globulin (human) administration.

HyperTET is made from human plasma. Products made from human plasma may contain infectious agents, such as viruses and theoretically, the Creutzfeldt-Jakob disease (CJD) agent that can cause disease. There is also the possibility that unknown infectious agents may be present in such products.

Please see full Prescribing Information for HyperTET.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.